 | Up a level |
Gillessen, Silke; Bossi, Alberto; Davis, Ian D; de Bono, Johann; Fizazi, Karim; James, Nicholas D; Mottet, Nicolas; Shore, Neal; Small, Eric; Smith, Matthew; Sweeney, Christopher J; Tombal, Bertrand; Antonarakis, Emmanuel S; Aparicio, Ana M; Armstrong, Andrew J; Attard, Gerhardt; Beer, Tomasz M; Beltran, Himisha; Bjartell, Anders; Blanchard, Pierre; ... (2023). Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022. European journal of cancer, 185, pp. 178-215. Elsevier 10.1016/j.ejca.2023.02.018
Gillessen, Silke; Bossi, Alberto; Davis, Ian D; de Bono, Johann; Fizazi, Karim; James, Nicholas D; Mottet, Nicolas; Shore, Neal; Small, Eric; Smith, Mathew; Sweeney, Christopher; Tombal, Bertrand; Antonarakis, Emmanuel S; Aparicio, Ana M; Armstrong, Andrew J; Attard, Gerhardt; Beer, Tomasz M; Beltran, Himisha; Bjartell, Anders; Blanchard, Pierre; ... (2023). Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022. European urology, 83(3), pp. 267-293. Elsevier 10.1016/j.eururo.2022.11.002
Armstrong, Andrew J; Li, Xiaotong; Tucker, Matthew; Li, Shantao; Mu, Xinmeng Jasmine; Eng, Kenneth Wha; Sboner, Andrea; Rubin, Mark; Gerstein, Mark (2021). Molecular medicine tumor board: whole-genome sequencing to inform on personalized medicine for a man with advanced prostate cancer. Prostate cancer and prostatic diseases, 24(3), pp. 786-793. Springer Nature 10.1038/s41391-021-00324-5
Beltran, Himisha; Oromendia, Clara; Danila, Daniel C; Montgomery, Bruce; Hoimes, Christopher; Szmulewitz, Russell Z; Vaishampayan, Ulka; Armstrong, Andrew J; Stein, Mark; Pinski, Jacek; Mosquera, Juan M; Sailer, Verena; Bareja, Rohan; Romanel, Alessandro; Gumpeni, Naveen; Sboner, Andrea; Dardenne, Etienne; Puca, Loredana; Prandi, Davide; Rubin, Mark A.; ... (2019). A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers. Clinical cancer research, 25(1), pp. 43-51. American Association for Cancer Research 10.1158/1078-0432.CCR-18-1912
